Role of analytical ultracentrifugation in assessing the aggregation of protein biopharmaceuticals.
about
Investigation of stable and transient protein-protein interactions: Past, present, and futureImproving the solubility of anti-LINGO-1 monoclonal antibody Li33 by isotype switching and targeted mutagenesisStructural insight for substrate tolerance to 2-deoxyribose-5-phosphate aldolase from the pathogen Streptococcus suisSize-exclusion chromatography can identify faster-associating protein complexes and evaluate design strategies.Some statistical properties of differencing schemes for baseline correction of sedimentation velocity dataBiophysical characterization of recombinant proteins: a key to higher structural genomics successOn computational approaches for size-and-shape distributions from sedimentation velocity analytical ultracentrifugation.Protein solubilization: a novel approach.A multilaboratory comparison of calibration accuracy and the performance of external references in analytical ultracentrifugation.Using prior knowledge in the determination of macromolecular size-distributions by analytical ultracentrifugation.A new adaptive grid-size algorithm for the simulation of sedimentation velocity profiles in analytical ultracentrifugationOverview of current methods in sedimentation velocity and sedimentation equilibrium analytical ultracentrifugation.Analytical tools for characterizing biopharmaceuticals and the implications for biosimilars.Detection and characterization of altered conformations of protein pharmaceuticals using complementary mass spectrometry-based approaches.A multi-tiered analytical approach for the analysis and quantitation of high-molecular-weight aggregates in a recombinant therapeutic glycoprotein.A bayesian approach for quantifying trace amounts of antibody aggregates by sedimentation velocity analytical ultracentrifugation.Improving the thermal, radial, and temporal accuracy of the analytical ultracentrifuge through external referencesOn the analysis of sedimentation velocity in the study of protein complexes.High-throughput biophysical analysis of protein therapeutics to examine interrelationships between aggregate formation and conformational stability.Size-Exclusion Chromatography for the Analysis of Protein Biotherapeutics and their AggregatesProtein-protein interactions: switch from classical methods to proteomics and bioinformatics-based approaches.Effects of syringe material and silicone oil lubrication on the stability of pharmaceutical proteins.Sedimentation velocity analytical ultracentrifugation for characterization of therapeutic antibodies.Molecular clusters size of Puerariae thomsonii radix aqueous decoction and relevance to oral absorption.A novel method for the collection of nanoscopic vesicles from an organotypic culture model.
P2860
Q27002299-99B398EA-F87E-479A-A7AE-14208A439E57Q27660092-EDC3D4BE-1E85-46CC-8583-4696D722E0BEQ27704506-2A9DA3E7-23B8-41D9-848C-285309A54E9DQ33482553-E387B8F1-1BCA-4184-B77D-9F4B969B7133Q33537518-A752FDA6-1489-406A-A264-FAAF0C27EEAFQ33577589-4E6464E6-B6CC-4409-94E7-DB20461405A3Q33940842-BEC9B34B-AAF7-4781-818B-0D93E60B950DQ34624409-75D694F6-9C23-460C-99BC-3DB18E360732Q35634385-DCB458BE-1E02-437E-90CE-D280196EDB70Q36014444-2EF9D443-EE2A-4762-BE5A-6919A8AD8F30Q36496332-9272D883-E681-43D6-B881-828116AC455EQ36838923-F941D823-E6C2-4331-9B7E-BE2B4F534CFDQ37022207-3C401920-397F-49A8-A3E3-A3799BC6AE8BQ37065997-6F00FD78-71F3-4A3C-8D83-2E2751BE8E04Q37214538-5C0728E2-9FFF-43E3-AB32-A0252FCE0158Q37228319-C7DA1CD7-B74F-42F0-925D-BA32C6F0309DQ37304742-E7C7C917-5DD7-453F-AE60-BFBEED71A7A7Q37371794-82149EF1-50A4-4680-8581-3DE126317A48Q37469381-E2E7C4AF-14AA-404A-A35E-343FC7BDEE43Q38078925-60672D9F-C8DB-4E8A-95E8-75E6BFC90511Q38098433-9AF02DE5-75B6-46C9-A0CB-9B1FC9B1CEEAQ43185460-5335D3D5-F011-4D7F-A9D9-57FBDC88E37EQ47247669-8203AADD-9C22-4FEE-A7B1-67306262EE2FQ47373506-C0418B42-6D99-43F2-9282-5B18829F0575Q52641488-685B37CB-6E42-42CA-9C87-01D351999B5F
P2860
Role of analytical ultracentrifugation in assessing the aggregation of protein biopharmaceuticals.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Role of analytical ultracentri ...... of protein biopharmaceuticals.
@ast
Role of analytical ultracentri ...... of protein biopharmaceuticals.
@en
type
label
Role of analytical ultracentri ...... of protein biopharmaceuticals.
@ast
Role of analytical ultracentri ...... of protein biopharmaceuticals.
@en
prefLabel
Role of analytical ultracentri ...... of protein biopharmaceuticals.
@ast
Role of analytical ultracentri ...... of protein biopharmaceuticals.
@en
P2860
P356
P1433
P1476
Role of analytical ultracentri ...... of protein biopharmaceuticals.
@en
P2093
Steven A Berkowitz
P2860
P2888
P304
P356
10.1208/AAPSJ080368
P407
P577
2006-09-22T00:00:00Z
P5875
P6179
1037140531